Home
/
Treatment
/
elacytarabine

elacytarabine

	elacytarabine
Trade Name
Orphan Indication	Acute myeloid leukemia
USA Market Approval	USA
USA Designation Date	2008-06-18 00:00:00
Sponsor	Clavis Pharma ASA;Parkveien 53 B;

Related Access Program

Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Celator Pharmaceuticals – Secondary AML University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia